In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.
about
Exosome-mediated small RNA delivery for gene therapyPreclinical and clinical development of siRNA-based therapeuticsPhosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analysesNew paradigms on siRNA local application.Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes.Short-interference RNAs: becoming medicines.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicinesInvestigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy.New pharmacotherapy for the treatment of glaucoma.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits.Novel therapeutics in glaucoma management.
P2860
Q26747740-F5222C3C-8C82-44C6-9F7E-079A02EB765CQ28085290-FF6FA98D-0066-4367-A4CA-77C4FEEA642EQ33554206-A22C65D7-000C-4C05-BE2E-C4758B748169Q35676356-2AB6FB1A-2527-4200-BA03-A009B848C558Q35890359-2FCE1BBD-7C30-4F43-8E0F-5A6F2735887EQ36347546-55FCBE26-D398-438E-8574-1641DCA39010Q38584194-BFB5D15A-54CC-4F21-8392-96D076167C51Q38674444-F36811FC-B4AF-46B8-9F58-C81D849E1308Q38934012-3B6248E0-1FBB-4BA1-AAB6-81DF57558C68Q39227810-DADFFF9E-8B0A-4AB1-9E81-BA6BE9193BF4Q41174369-6D06B369-2FCD-42F0-997F-4B446E41B08BQ46061291-F8DC5A59-018E-4248-83A8-F46249EF3D31Q48263612-CB059A63-091D-4CAB-848C-B02F2CB2585EQ48282746-18664BA1-3928-44DA-AAF5-4BA8BC13B6BCQ48602585-0959E913-9754-4044-8A3C-5B31EDE95352Q50023818-0A0D8F13-9309-438D-AC14-0E388D11340F
P2860
In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@en
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@nl
type
label
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@en
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@nl
prefLabel
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@en
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@nl
P2093
P2860
P356
P1433
P1476
In vitro and in vivo efficacy ...... und for treatment of glaucoma.
@en
P2093
Ana Isabel Jiménez
Covadonga Pañeda
Ingo Roehl
Maria Victoria González
Natalia Wright
Tamara Martínez
P2860
P356
10.1038/MT.2013.216
P577
2013-09-12T00:00:00Z